english.prescrire.org > Topics > Advancing healthcare policy > Advancing healthcare policy in Europe: a chronological recap of actions > 2022 Recap > EMA's response to Prescrire's analysis of EMA's transparency policy over the last 10 years (September 2022)

Advancing healthcare policy

Advancing healthcare policy in Europe: a chronological recap of actions

A recap of actions in 2022
EMA's response to Prescrire's analysis of EMA's transparency policy over the last 10 years (September 2022)

The reply by the European Medicines Agency's Executive Director, in response to Prescrire's critique of the Agency's transparency policy, with comments added by Prescrire, appears in the September 2022 issue of Prescrire International.

 

Prescrire sent a copy of its article "European Medicines Agency: transparency policy marred by too many failings" (available >HERE) to Emer Cooke, Executive Director of the European Medicines Agency.

In this article, Prescrire calls for an official inquiry in order to analyse the causes of EMA's failings, and to enable Members of the European Parliament to take appropriate steps.

Emer Cooke's reply (20 May 2022) appears in the September 2022 issue of Prescrire International, with comments added by Prescrire.

Full text available for free download below.

©Prescrire 1 September 2022

Source: "Queries and comments. EMA's response to Prescrire's analysis of EMA's transparency policy over the last 10 years" Prescrire International 2022; 31 (240): 220-222. Free.

Enjoy full access to Prescrire International, and support independent information

Share
Share on Facebook Share on Twitter